TY - CHAP M1 - Book, Section TI - Cardiovascular Disease Prevention in Women A1 - Dolan, Brigid A1 - Walsh, Judith A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. Y1 - 2023 N1 - T2 - Current Medical Diagnosis & Treatment 2023 AB - CVD is the leading cause of death in women. Women's heart disease risk tends to lag about 10 years behind that of men; thus, at any given age, a woman's baseline risk will be lower than that of a man's baseline risk. While some heart disease risk factors such as age and family history are not modifiable, other risk factors such as hypertension, hyperlipidemia, smoking, obesity, and diabetes are potentially modifiable. Additionally, sex-specific risk factors may impact a woman's risk of future heart disease, including adverse pregnancy outcomes (ie, preeclampsia, gestational diabetes, preterm birth, or small for gestational age birth), premature ovarian failure or early menopause, or comorbidities such as autoimmune disease or the sequelae of cancer treatments (ie, chest wall radiation, or trastuzumab or anthracycline treatment for breast cancer). Each of these may be considered a "risk-enhancer" when considering future CVD risk. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/12 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193123124 ER -